Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
Denali Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 19, 2022
Denali Therapeutics reported fiscal year 2021 executive compensation information on April 19, 2022.
In 2021, four executives at Denali Therapeutics received on average a compensation package of $8.1M, a 46% increase compared to previous year.
Average pay of disclosed executives at Denali Therapeutics
Ryan J. Watts, Chief Executive Officer, received $13M in total, which increased by 36% compared to 2020. 58% of Watts' compensation, or $7.3M, was in option awards. Watts also received $503K in bonus, $610K in salary, $4.3M in stock awards, as well as $12K in other compensation.
Steve E. Krognes, Chief Financial Officer, received a compensation package of $6.6M, which increased by 54% compared to previous year. 55% of the compensation package, or $3.6M, was in option awards.
Carole Ho, Chief Medical Officer, earned $6.5M in 2021, a 51% increase compared to previous year.
Alexander O. Schuth, Chief Operating Officer, received $6.5M in 2021, which increases by 55% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 19, 2022.